Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Growth Accelerates: Strategic Forecast Predicts $2.51 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Industry Market Size Be by 2025?
The market size of percutaneous transluminal coronary angioplasty (PTCA) dilation catheters has seen robust growth in the past few years. It is expected to grow from $1.83 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The growth during the historic period has been fueled by numerous factors, including a rising incidence of cardiovascular diseases, an aging population, increasing preference for less invasive procedures, escalating obesity rates, and enhanced healthcare infrastructure.

What's the Long-Term Growth Forecast for the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Size Through 2029?
In the upcoming years, the market size of percutaneous transluminal coronary angioplasty (PTCA) dilation catheters is predicted to witness robust growth, increasing to $2.52 billion by 2029 at a compound annual growth rate (CAGR) of 6.5%. This projected growth for the forecast period is attributed to factors such as heightened focus on preventive healthcare, patients favoring shorter duration of hospital stays, advantageous repayment policies, rising use of drug-eluting balloons, and advancements in diagnostic procedures. Key trends expected throughout the forecast period encompass technological progress, spread into new markets, enhanced patient awareness, personalized catheters, and harmony with imaging technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/percutaneous-transluminal-coronary-angioplasty-ptca-dilation-catheters-global-market-report

What Are the Key Growth Drivers Fueling the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Expansion?
The escalating prevalence of cardiovascular conditions is predicted to stimulate the expansion of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market. This rise in cardiovascular ailments is attributed to lifestyle aspects such as inadequate diet, insufficient physical activity, escalating stress, coupled with a globally aging population. PTCA dilation catheters are employed in treating cardiovascular diseases to rectify narrowed or blocked coronary arteries, re-establishing heart's blood circulation. For example, in June 2024, the American Heart Association, a US-based public health entity promoting cardiovascular medical research, estimated that 45 million adults in the USA will likely have some form of cardiovascular disease by 2050, an increase from 28 million in 2020. This estimate includes a considerable surge in hypertension, anticipated to grow from 51.2% to 61.0%, and obesity, predicted to rise from 43.1% to 60.6%. Hence, this escalation in cardiovascular conditions is fuelling the expansion of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19641&type=smp

What Are the Key Trends Driving Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Growth?
Key players in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are striving to develop innovative products such as dilation catheters that incorporate twin-wall technology, which increases balloon strength and improves artery dilation. Twin-wall technology in dilation catheters, which are medical devices, is characterized by a unique dual-layer construction that boosts the strength, durability, and flexibility of the catheter. For example, SIS Medical AG, a firm based in Switzerland that manufactures medical devices, introduced the OPN NC PTCA dilatation catheter with Twin-Wall technology in the USA in February 2023. The catheter demonstrates incredible high-pressure resistance with a rated burst pressure of 35 atm and low compliance, making it ideal for the post-dilatation of under-expanded stents. Its unique design allows it to effectively treat difficult coronary lesions without the fear of over-dilation due to its remarkable pressure resistance and extremely low compliance.

How Is the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Segmented?
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market covered in this report is segmented -

1) By Type: Semi-Compliant Type, Non-Compliant Type
2) By Material Type: Polyurethane, Nylon, Other Material Types
3) By Application: Hospitals, Medical Research Institute, Other Applications

Subsegments:
1) By Semi-Compliant Type: Standard Semi-Compliant Catheters, Specialized Semi-Compliant Catheters
2) By Non-Compliant Type: Standard Non-Compliant Catheters, High-Pressure Non-Compliant Catheters

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19641&type=smp

Which Companies Are Leading the Charge in Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Innovation?
Major companies operating in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton inson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group

Which Regions Are Leading the Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market in Revenue?
North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2024. The regions covered in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19641

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.